by country – Page 2 – Retraction Watch

Pain researcher in Italy up to seven retractions

A physiatrist in Italy has lost four publications this year after two groups of researchers raised concerns about his research.

The physician, Marco Monticone, a professor at the University of Cagliari, had three papers pulled in 2022, as we reported at the time. Those retractions followed a critique by Cochrane researchers who analyzed data in 10 randomized controlled trials (RCTs) headed by Monticone.

Neil O’Connell, of Brunel University of London, lead author of the critique, told us:

New engineering dean has two retractions for authorship manipulation

A newly appointed dean at the University of Guelph in Canada has had two papers retracted for “evidence of authorship manipulation.”

Another article by the researcher, Moncef Nehdi, formerly of McMaster University in Hamilton, Ontario, seems to match a paper that had its authorship advertised for sale, according to a post on PubPeer.

Nehdi told Retraction Watch he stands by his group’s work in the two retracted papers, but agreed with the retractions because he thought the investigations “raised some valid concerns.”

Nehdi began a five-year term as dean of the University of Guelph’s College of Engineering and Physical Sciences on September 1, according to an announcement this spring. The announcement stated:

Penn State barred embattled professor from doing research

The Pennsylvania State University in May blocked a prominent professor at the school from doing research and making presentations on its behalf, Retraction Watch has learned.

The professor, Deborah Kelly, has faced mounting scrutiny over her work since a researcher in the United Kingdom noticed apparent data manipulation in a now-retracted article she published in 2017. Kelly earned her third retraction last week following a university probe that found “serious data integrity concerns” in another paper, as we reported at the time.

In comments she made via her legal counsel for that story, Kelly, a biomedical engineer and an expert in electron microscopy, told us:

Nobel prize-winner tallies two more retractions, bringing total to 13

A Nobel prize-winning genetics researcher has retracted two more papers, bringing his total to 13.

Gregg Semenza, a professor of genetic medicine and director of the vascular program at Johns Hopkins’ Institute for Cell Engineering in Baltimore, shared the 2019 Nobel prize in physiology or medicine for “discoveries of how cells sense and adapt to oxygen availability.”

Since pseudonymous sleuth Claire Francis and others began using PubPeer to point out potential duplicated or manipulated images in Semenza’s work in 2019, the researcher has retracted 12 papers. A previous retraction from 2011 for a paper co-authored with Naoki Mori – who with 31 retractions sits at No. 25 on our leaderboard – brings the total to 13.

Penn State prof earns second retraction, faces third following university probe

A professor of biomedical engineering at the Pennsylvania State University today lost a government-funded study in Science Advances, marking her second retraction.

The researcher, Deborah Kelly, is also facing retraction of a paper in Current Opinion in Structural Biology after a review undertaken by her institution found “serious data integrity concerns” in the work, according to emails obtained by Retraction Watch. Kelly has hired a lawyer to fight the retraction, apparently without success. (Update on Sept. 12: The paper has now been retracted.)

Today’s retraction of “Structural analysis of BRCA1 reveals modification hotspot” cites “unresolved concerns in the integrity of the data presented,” including what appears to be alterations of cryogenic electron microscopy (cryo-EM) maps using an “eraser tool.” The study was funded in part through a National Institutes of Health (NIH) grant for US$353,386 to Kelly.

In a statement to Retraction Watch sent via her legal counsel, Kelly stood by her work.

Pakistan university’s pharmacy department chair notches two retractions

Kashif Barkat, who heads the Department of Pharmacy at the University of Lahore in Punjab, Pakistan, has had two of his studies retracted and two more corrected, all for issues related to images in the papers. Several more of his studies are flagged on PubPeer for similar reasons.

According to the retraction notice for one of the retracted articles, which appeared in Polymer Bulletin in 2020, Barkat does not agree with the journal’s decision to pull the paper.

The paper, “Understanding mechanical characteristics of pH-responsive PEG 4000-based polymeric network for colorectal carcinoma: its acute oral toxicity study,” has been cited three times so far, according to Clarivate’s Web of Science.

The retraction note, issued in June, reads:

Swiss medical association accused of forcing publishing subsidiary into insolvency

A Swiss medical publisher has ceased operations, including shuttering nationally prominent journals, after its parent organization, the Swiss Medical Association FMH, allegedly forced it into bankruptcy.

According to information on the website of EMH Swiss Medical Publishers, the Swiss Medical Association FMH holds a 55% stake in the firm. But on Aug. 22, 2024, the FMH’s board terminated its collaboration with the publishing house, including licensing for the association’s journal Schweizerische Ärztezeitung (Swiss Medical Journal), with immediate effect.

“In doing so, [the association] deprived its own company of its livelihood. EMH filed its balance sheet today and thus opened bankruptcy proceedings,” the publisher said in a notice posted on its website on September 4, 2024.

Faked heart papers retracted following Ohio State investigation

A physiology journal has retracted two papers after an institutional investigation found a heart researcher falsified data and figures in the articles.

A committee at the Ohio State University found Govindasamy Ilangovan, an associate professor of cardiovascular medicine at the school, falsified figures and reused data, according to the retraction notices published in Heart and Circulatory Physiology, a journal of the American Physiological Society.

The two papers, “Heat shock protects cardiac cells from doxorubicin-induced toxicity by activating p38 MAPK and phosphorylation of small heat shock protein 27,” and “HSP27 regulates p53 transcriptional activity in doxorubicin-treated fibroblasts and cardiac H9c2 cells: p21 upregulation and G2/M phase cell cycle arrest,” first appeared nearly 20 years ago. They have received 132 citations in total, according to Clarivate’s Web of Science.

The notices detail how Ilangovan repurposed and relabelled Western blots from both published and unpublished works. One of the figures also was “inaccurate” due to “addition of false bands” in a Western blot, but the notice did not explicitly attribute the problems with the figure to Ilangovan.

Author blames retraction on ‘Chinese censorship’

A former assistant professor of international relations at Yibin University in Sichuan, China, said he was fired from his job and “forced” to retract a paper on COVID-19 because the article did not “paint a good picture of the Chinese government.”

In the 2021 paper, Thomas Ameyaw-Brobbey, now an adjunct lecturer at Accra Business School in Ghana and an adjunct research fellow at the Ghana Armed Forces Command and Staff College, discussed the negative effects of the pandemic on the global public opinion of Chinese leadership and how the outbreak fostered an “unfavorable image” of China.

After the article appeared in the Journal of International Studies, authorities at Yibin University held several meetings with Ameyaw-Brobbey asking him to explain the paper and why he used a dataset of public opinion in the United States that was “likely to be biased towards China,” he said.

Finland group downgrades 60 journals

A panel of scholars in Finland has downgraded 60 journals in their quality rating system, following months of review and feedback from researchers.

The Finnish Publication Forum (JUFO) classifies and rates journals and other scholarly publications to “support the quality assessment of academic research,” according to its website. JUFO considers the level of transparency, the number of experts on a publication’s editorial board, and the standard of peer review to make its assessment, which academics can use to determine the credibility of a given title or its publisher.

JUFO’s classification ranges from 3, for “supreme-level” publications, to 1, which still counts as legitimate publication. Level 0 means the journal is excluded from the ranking, which may dissuade researchers from publishing with them, James Heathers, a scientific sleuth said. Finland’s university funding model relies on JUFO as a publication quality metric.

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this:

Share this: